Gibson, Dunn & Crutcher advised Alcon Inc. on the deal, and Morrison & Foerster advised OcuMension Therapeutics. OcuMension Therapeutics (“OcuMension”), a Hong Kong-listed, China-based ophthalmic pharmaceutical...
Ocumension Therapeutics’ Acquisition of Alcon’s Rights
Alcon Inc.’s $1.32 Billion Revolving Credit Facility
Homburger advised Alcon Inc. on the deal. Alcon Inc. (SIX: ALC), a leading eye care product company, in its capacity as Borrower and Guarantor entered into...
AMO Development LLC et al. v. Alcon Inc. et al.
Latham & Watkins and Morris Nichols represented J&J Vision and the J&J plaintiffs, while Shaw Keller and Kirkland & Ellis represented Alcon Inc. and the Alcon...
In re: Disposable Contact Lens Antitrust Litigation
Robins Kaplan LLP has reached settlements in excess of $118 million on behalf of U.S. contact lens purchasers in an expansive antitrust class action against the...
Alcon’s Acquisition of Aerie Pharmaceuticals
Skadden, Arps, Slate, Meagher & Flom represented Alcon, while Fried, Frank, Harris, Shriver & Jacobson represented Aerie in the transaction. Alcon entered into a definitive merger...
Alcon’s Acquisition of U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza
Skadden, Arps, Slate, Meagher & Flom LLP advised Alcon on the deal. Alcon, the global leader in eye care dedicated to helping people see brilliantly, has...